Shares of Profusa (PFSA) hit a record low on Thursday, crashing 28% after the biotech company announced its second reverse ...

That is a big risk investors take when trying to find the winners and losers within the biotech sector. While we made the ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts. Syndax Pharmaceuticals, ...

The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is ...

Biotechnology is enjoying one of its strongest years in recent times, which is mostly fueled by a rebound in capital markets, ...

It has been a banner year for biotech buyouts, and these are two of the prime targets.

Biotech is now the deepest pocket of leadership in the entire Nasdaq. Everyone can see biotech is moving, and the why is ...

Viking Therapeutics (NASDAQ: VKTX) is one of the hopefuls in a very exciting pharmaceutical and biotech space right now: the ...

Customs Department has initiated probe against its general manager, sales and marketing officer Sreekant Sreedharan of ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

Morgan Stanley’s pivot is from “chip winners” to hyperscalers with AI infrastructure optionality. MSFT has the strongest mix ...

China and Hong Kong stocks rose on Monday as signs emerged that investor enthusiasm for artificial intelligence was ...